Form 8-K - Current report:
SEC Accession No. 0001104659-25-061148
Filing Date
2025-06-20
Accepted
2025-06-20 16:05:09
Documents
3
Period of Report
2025-06-20
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2518546d1_8k.htm 8-K 20570
2 EXHIBIT 3.1 tm2518546d1_ex3-1.htm EX-3.1 54610
3 EXHIBIT 3.2 tm2518546d1_ex3-2.htm EX-3.2 161020
  Complete submission text file 0001104659-25-061148.txt   237479
Mailing Address 750 W JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039
Business Address 750 W JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039 (866) 771-8946
Caris Life Sciences, Inc. (Filer) CIK: 0002019410 (see all company filings)

EIN.: 852077369 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42706 | Film No.: 251061298
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)